CalEthos, Inc. - FORM 8-K - December 13, 2012

Attached files

file	filename
EX-3.1 - CERTIFICATE OF CHANGE - CalEthos, Inc.	ex3-1.txt

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

       Date of report (Date of earliest event reported): December 4, 2012


                            UPSTREAM BIOSCIENCES INC.
             (Exact name of registrant as specified in its charter)

          Nevada                     000-50331                   98-0371433
(State or other jurisdiction        (Commission                (IRS Employer
     of incorporation)              File Number)             Identification No.)

50 West Liberty Street, Suite 880, Reno, NV                        89501
  (Address of Principal Executive Offices)                       (Zip Code)

        Registrant's telephone number, including area code: 403-537-2516

                                       N/A
          (Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
    230.425)

[ ] Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17 CFR
    240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
    Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
    Act (17 CFR 240.13e-4(c))

ITEM 5.03 AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL
          YEAR

On December 4, 2012,  we effected a one (1) for  thirty-five  (35) reverse stock
split of our authorized and issued and outstanding  common stock. Our authorized
capital of the common  stock will remain at  100,000,000  shares of common stock
and our issued and outstanding  capital will decrease from 69,112,065  shares of
common stock to  approximately  1,974,630  shares of common stock. Our new CUSIP
number is 91678P 203.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

(d) Exhibits

3.1   Certificate of Change dated effective December 4, 2012


                                       2

                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

UPSTREAM BIOSCIENCES INC.


/s/ Charles El-Moussa
--------------------------------------------
Charles El-Moussa
President, Secretary, Treasurer and Director
Date: December 13, 2012
CalEthos, Inc. - FORM 8-K - December 13, 2012

Attached files

CalEthos, Inc. Reports
